Medicines: Denosumab, Apremilast, Rivaroxaban, etc.
Original notice title
Spain – Pharmaceutical products – Medicamentos: Denosumab, Apremilast, Rivaroxaban, Dabigatran, Nintedanib, Golimumab y Pazopanib
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Buyer
Name
ICS - Gerència de compres
Location
No consta, ESP
Identifier
204588
Lots (1)
LOT-0000
Medicamentos: Denosumab, Apremilast, Rivaroxaban, Dabigatran, Nintedanib, Golimumab y Pazopanib
CS/CC00/1101472323/26/AM: Acuerdo marco para el suministro agregado de medicamentos Denosumab, Apremilast, Rivaroxaban, Dabigatran, Nintedanib, Golimumab y Pazopanib para los centros del l'Institut Català de la Salut y centros adheridos: Hospital del Mar de Barcelona, Sant Joan de Reus-Baix Camp, Hospital de Cerdanya – AECT Agrupació Europea de Cooperació Territorial, Institut d'Assistència Sanitària i Gestió de Serveis Sanitaris
Location
Duration
Category
Award details
Procurement Details
- Publication date
- 18 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- Spanish, Cat
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 421284-2026
Documents (1)
Similar tenders
Denmark – Pharmaceutical products – Amgros 2027 1.1051.b
Poland – Pharmaceutical products – Dostawa produktów leczniczych do SPZZOZ w Wyszkowie
Romania – Pharmaceutical products – MEDICAMENTE - PRODUSE FARMACEUTICE
Denmark – Pharmaceutical products – Amgros 2027 1.1052.b
Latvia – Pharmaceutical products – Par reģistrēto un nereģistrēto medikamentu piegādi Elektronisko iepirkumu sistēmas dalībniekiem
Spain – Pharmaceutical products – Suministro de Aflibercept (DOE) Intravítreo 40 mg/ml
Opportunity Score
Why this score?
Opportunity
0 / 100
Complexity
0 / 100
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications